Purchase Order 75D30125P20666
Award Date 9/30/25
Potential Completion Date 9/29/27
Potential Value $56K
Federal Agency
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Fremont, CA 94538, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This firm fixed-price purchase order was awarded to Biolytic Lab Performance Inc., a veteran-owned for-profit organization, by the Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia. The $54,000 contract is for the maintenance of a medium throughput DNA synthesizer and 42 related reagents. The award was not set aside for any specific business category. Biolytic Lab Performance Inc. specializes in providing scientific instrumentation, particularly oligonucleotide synthesizers...
- The U.S. Centers for Disease Control and Prevention (CDC) awarded a firm fixed-price purchase order contract to Biolytic Lab Performance Inc., a veteran-owned for-profit organization, for the procurement of a DR. OLIGO Synthesizer. The contract, valued at $84,950.00, has an ultimate completion date of April 30, 2020. Biolytic Lab Performance Inc. is a federal contractor that specializes in DNA synthesis solutions and laboratory equipment, and has secured multiple awards from various civilian and...
- This is a firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Biolytic Lab Performance Inc., a veteran-owned, for-profit organization that specializes in DNA synthesis solutions. The contract, valued at $56,000.00, is for the maintenance of Biolytic's DR. OLIGO 48 DNA synthesizers. The contract has a completion date of February 9, 2026. Biolytic Lab Performance Inc. has extensive experience providing DNA synthesizers, related instruments,...
- This is a $95,700 firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Biolytic Lab Performance Inc., a veteran-owned for-profit company specializing in DNA synthesis solutions and laboratory equipment. The contract is for the procurement of a DR.OLIGO 48 DNA synthesizer, which allows the CDC to synthesize oligonucleotides at a much higher capacity with reduced turnaround time and argon gas consumption. This sole-source contract is based...
- The Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) awarded Biolytic Lab Performance Inc., a for-profit, veteran-owned business, a firm-fixed-price purchase order contract for $42,600.00. The contract is for an annual service agreement with a completion date of August 9, 2025. The original solicitation was for 500 mL of Avantor Seradigm Premium Grade Fetal Bovine Serum. This contract does not have a set-aside designation. Biolytic Lab Performance...
- This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Biolytic Lab Performance Inc., a veteran-owned for-profit organization. The contract, valued at $84,950.00, is for the provision of an OLIGO INST (oligonucleotide instrument), with a performance period ending on July 20, 2021. The contract has no set-aside designation. Biolytic Lab Performance Inc. is a provider of DNA synthesis solutions and laboratory equipment, having secured...
- The Centers for Disease Control and Prevention (CDC) Pittsburgh awarded a definitive, firm fixed-price lab equipment maintenance agreement to Life Technologies Corporation (doing business as Thermo Fisher Scientific) on July 3, 2024, with a ceiling value of $8.03 million and performance through June 30, 2029. This non-set-aside contract supports maintenance services for scientific laboratory equipment at the CDC's Atlanta, Georgia facility. Life Technologies Corporation is a leading manufacturer...
- The Centers for Disease Control and Prevention (CDC) awarded a $161,647.50 firm fixed-price purchase order to Eppendorf North America, Inc. for a five-year onsite service agreement covering maintenance of two epMotion 5075t next-generation sequencing (NGS) solution instruments at the CDC Division of Vector Disease in Fort Collins, Colorado. The contract, awarded on April 9, 2025, with an ultimate completion date of April 7, 2030, encompasses planned and unplanned service events, replacement...
- The federal government awarded a $109,100 firm-fixed-price purchase order contract to Life Technologies Corporation, a subsidiary of parent company Thermo Electron Corporation, to provide biomedical research equipment, reagents, and associated services to the Centers for Disease Control and Prevention (CDC) Pittsburgh office. This contract is not associated with any set-aside designation. Life Technologies is an experienced provider of scientific instruments, consumables, and technical support...
- The Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh awarded a $49,900 firm fixed price purchase order to Bionano Genomics, Inc. of San Diego, California for the delivery of a purification system. The contract is being carried out from September 14, 2023 through October 30, 2023 to support the CDC's efforts. No subcontractors or set aside designations were indicated. The award provides Bionano Genomics the opportunity to supply specialized...